you are here: Home News Ajanta Pharma

Ajanta Pharma

Buy Ajanta Pharma; target of Rs 3200: Prabhudas Lilladher
Trade Spotlight: How should you trade Bayer Cropscience, Jindal Stainless, General Insurance Corp, HUL, Bharti Hexacom, JSW Steel and others on August 1?
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
Trade Spotlight: How should you trade Ajanta Pharma, Hyundai Motor India, Max Healthcare Institute, Nelcast, Cera Sanitaryware and others on June 13?
Reduce Ajanta Pharma: target of Rs 2500: ICICI Securities
Ajanta Pharma Consolidated March 2025 Net Sales at Rs 1,170.41 crore, up 11.04% Y-o-Y
Ajanta Pharma Standalone March 2025 Net Sales at Rs 1,013.94 crore, up 9.49% Y-o-Y
Buy Ajanta Pharma; target of Rs 3180: Choice Equity Broking
Buy Ajanta Pharma; target of Rs 3260: Motilal Oswal
Ajanta Pharma shares gain 10%, hit six-week high on surging volumes
Trade Spotlight: How should you trade Tech Mahindra, Zomato, Ajanta Pharma, IndiGo, JSW Steel, and others on February 19?
Buy Ajanta Pharma; target of Rs 3220: Motilal Oswal
Ajanta Pharma Consolidated December 2024 Net Sales at Rs 1,146.13 crore, up 3.71% Y-o-Y
Ajanta Pharma Standalone December 2024 Net Sales at Rs 1,101.92 crore, up 1.53% Y-o-Y
Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree Cement, Tata Consumer in focus on 31 January
Ajanta Pharma Consolidated September 2024 Net Sales at Rs 1,186.64 crore, up 15.38% Y-o-Y
Buy Ajanta Pharma; target of Rs 3470: Motilal Oswal
Stock Radar: Bharti Airtel, Adani Power, Suzlon, Federal Bank, Quess Corp, Genesys International in focus on Tuesday
Buy Ajanta Pharma; target of Rs 2935: Motilal Oswal
Ajanta Pharma Standalone June 2024 Net Sales at Rs 1,077.27 crore, up 6.18% Y-o-Y
Ajanta Pharma Consolidated March 2024 Net Sales at Rs 1,054.08 crore, up 19.53% Y-o-Y
Buy Ajanta Pharma; target of Rs 2,565: Motilal Oswal
Ajanta Pharma Standalone March 2024 Net Sales at Rs 926.07 crore, up 9.1% Y-o-Y
Ajanta Pharma shares zoom 14% on stellar Q4 earnings, buyback plans

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Ajanta Pharma

Buy Ajanta Pharma; target of Rs 3200: Prabhudas Lilladher

Trade Spotlight: How should you trade Bayer Cropscience, Jindal Stainless, General Insurance Corp, HUL, Bharti Hexacom, JSW Steel and others on August 1?

Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y

Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y

Trade Spotlight: How should you trade Ajanta Pharma, Hyundai Motor India, Max Healthcare Institute, Nelcast, Cera Sanitaryware and others on June 13?

Reduce Ajanta Pharma: target of Rs 2500: ICICI Securities

Ajanta Pharma Consolidated March 2025 Net Sales at Rs 1,170.41 crore, up 11.04% Y-o-Y

Ajanta Pharma Standalone March 2025 Net Sales at Rs 1,013.94 crore, up 9.49% Y-o-Y

Buy Ajanta Pharma; target of Rs 3180: Choice Equity Broking

Buy Ajanta Pharma; target of Rs 3260: Motilal Oswal

Ajanta Pharma shares gain 10%, hit six-week high on surging volumes

Trade Spotlight: How should you trade Tech Mahindra, Zomato, Ajanta Pharma, IndiGo, JSW Steel, and others on February 19?

Buy Ajanta Pharma; target of Rs 3220: Motilal Oswal

Ajanta Pharma Consolidated December 2024 Net Sales at Rs 1,146.13 crore, up 3.71% Y-o-Y

Ajanta Pharma Standalone December 2024 Net Sales at Rs 1,101.92 crore, up 1.53% Y-o-Y

Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree Cement, Tata Consumer in focus on 31 January

Ajanta Pharma Consolidated September 2024 Net Sales at Rs 1,186.64 crore, up 15.38% Y-o-Y

Buy Ajanta Pharma; target of Rs 3470: Motilal Oswal

Stock Radar: Bharti Airtel, Adani Power, Suzlon, Federal Bank, Quess Corp, Genesys International in focus on Tuesday

Buy Ajanta Pharma; target of Rs 2935: Motilal Oswal

Ajanta Pharma Standalone June 2024 Net Sales at Rs 1,077.27 crore, up 6.18% Y-o-Y

Ajanta Pharma Consolidated March 2024 Net Sales at Rs 1,054.08 crore, up 19.53% Y-o-Y

Buy Ajanta Pharma; target of Rs 2,565: Motilal Oswal

Ajanta Pharma Standalone March 2024 Net Sales at Rs 926.07 crore, up 9.1% Y-o-Y

Ajanta Pharma shares zoom 14% on stellar Q4 earnings, buyback plans